ChemicalBook
English   Japanese   Germany   Korea

Bimosiamose

Bimosiamose, 187269-40-5, 结构式
Bimosiamose
CAS号:
187269-40-5
英文名:
Bimosiamose
英文别名:
TBC-1269;Bimosiamose;[1,1'-Biphenyl]-3-acetic acid, 3',3'''-(1,6-hexanediyl)bis[6'-(α-D-mannopyranosyloxy)-
中文名:
Bimosiamose
中文别名:
比莫西糖;化合物 T14574
CBNumber:
CB51401694
分子式:
C46H54O16
分子量:
862.92
MOL File:
187269-40-5.mol

Bimosiamose化学性质

熔点:
115-117°
沸点:
1051.0±65.0 °C(Predicted)
密度:
1.417±0.06 g/cm3(Predicted)
储存条件:
Store at -20°C
溶解度:
DMSO:100.0(Max Conc. mg/mL);115.89(Max Conc. mM)
0.1 M NaOH:25.0(Max Conc. mg/mL);28.97(Max Conc. mM)
形态:
A crystalline solid
酸度系数(pKa):
3.95±0.10(Predicted)
安全信息

Bimosiamose性质、用途与生产工艺

生物活性

Bimosiamose (TBC-1269) 是一种非寡糖泛-selectin 拮抗剂,对 E-selectin,P-selectin 和 L-selectin 的 IC50 分别为 88 μM,20 μM 和 86μM。Bimosiamose 具有抗炎作用。

靶点

IC50: 88 μM (E-selectin), 20 μM (P-selectin), 86 μM (L-selectin)

体外研究

Bimosiamose (TBC-1269) operates by inhibiting neutrophil recruitment to the site of inflammation through blocking the initial rolling phase of recruitment. Bimosiamose (TBC-1269) inhibits cell recruitment and does not possess any cytotoxic effect on neutrophils.

体内研究

Bimosiamose (TBC-1269; 25 mg/kg; intravenous injection; Sprague-Dawley rats) treatment shows a significant increase in survival. Best overall survival, 70%, is observed when TBC-1269 is administered 15 minutes before reperfusion, and also shows a marked decrease in liver enzyme levels at 6 hours after reperfusion. Neutrophil migration is also significantly ameliorated (81%). The histologic damage scores is also improved.

Animal Model: Sprague-Dawley rats (200-225g) with ischemia and reperfusion (I/R)
Dosage: 25 mg/kg
Administration: Intravenous injection
Result: Showed a significant increase in survival compared with controls.

Bimosiamose 上下游产品信息

上游原料

下游产品

Bimosiamose 试剂级价格

更新日期产品编号产品名称CAS编号包装价格
2024/04/30HY-106139Bimosiamose
Bimosiamose
187269-40-51mg600元
2024/04/30HY-106139Bimosiamose
Bimosiamose
187269-40-55mg1800元

Bimosiamose 生产厂家

全球有 15家供应商   Bimosiamose国内生产厂家
供应商联系电话电子邮件国家产品数优势度
四川省维克奇生物科技有限公司 028-81700200 18116577057 3003855609@qq.com 中国 7892 56
济南尚博医药股份有限公司 0531-61320525 15866703830 495745175@qq.com 中国 6690 58
济南尚博生物科技有限公司 +8615866703830 figo.gao@foxmail.com 中国 7154 58
TargetMol Chemicals Inc. +1-781-999-5354 +1-00000000000 marketing@targetmol.com 美国 19892 58
ChemeGen 中国 18818260767 sales@chemegen.com 中国 11289 58
天津普西唐生物医药科技有限公司 010-60605840 psaitong@jm-bio.com 中国 29778 58
开封明仁药业有限公司 0371-65741762 sales@hasunny.com 中国 2380 58
济南路远生物医药科技有限公司 13210587493 jinanluyuan@hotmail.com 中国 341 58
苏州美石生物科技有限公司 1173954148q meishipharma@126.com 中国 20035 58
上海一飞生物科技有限公司 021-65675885 18964387627 customer_service@efebio.com 中国 8740 58
TargetMol中国(陶术生物) 15002134094 marketing@targetmol.com 中国 24246 58
Shanghai Acmec Biochemical Technology Co., Ltd. +undefined18621343501 product@acmec-e.com 中国 33350 58
 

187269-40-5, Bimosiamose 相关搜索:

  • 对照品
  • C46H54O16
  • 化合物 T14574
  • 比莫西糖
  • 187269-40-5
  • [1,1'-Biphenyl]-3-acetic acid, 3',3'''-(1,6-hexanediyl)bis[6'-(α-D-mannopyranosyloxy)-
  • TBC-1269
  • Bimosiamose
Copyright 2016 © ChemicalBook. All rights reserved